
Vas Narasimhan (the CEO, Novartis) has named it directly: becoming the number one partner in the technology ecosystem is one of Novartis’s four digital strategic pillars. That is not aspirational language dropped into an investor deck. It is explicit ecosystem intent at CEO level, and it is rare in global pharma.
Novartis has acted on it. Two remarkable architectures now exist inside the company, each sophisticated enough to be a case study on its own.
I took a look at Novatis and its intent though a different approach here, exploring the results from the Intelligent Integrated Business Ecosystem (IIBE) and raising some fairly important Ecosystem building questions on Novartis, based on my analysis as part of the Healthcare research undertaken
So these two remarkable architectures seem to have so much value left on the table. There seems much to do on taking these to a very different level
Continue reading







